NOVA

0.400

-0.005 (-1.2%)

Change in Boardroom

NOVA WELLNESS GROUP BERHAD

Date of change 26 Aug 2025
Name DATUK DR MUHAMMAD RADZI BIN ABU HASSAN
Age 60
Gender Male
Nationality Malaysia
Designation Director
Directorate Independent and Non Executive
Type of change Appointment

Qualifications

No
Qualifications
Major/Field of Study
Institute/University
Additional Information
Degree
Bachelor’s degree
MBBS
Bachelor of Medicine, Bachelor of Surgery and Bachelor of Obstetrics
National University of Ireland
Professional Qualification
Professional certification
LRCP
Licentiate of the Royal College of Physicians
Royal College of Physicians
Professional Qualification
Professional certification
MRCP
Member of the Royal College of Physicians
Royal College of Physicians
Masters
Master’s degree 
M. MED
Master of Medicine
Universiti Sains Malaysia
Others
Fellowship
FRCP
Fellow of the Royal College of Physicians
Royal College of Physicians (Edinburgh)]
Others
Fellowship
FAMM
Fellow of the Academy of Medicine of Malaysia
Academy of Medicine of Malaysia

Working experience and occupation
Datuk Dr Muhammad Radzi bin Abu Hassan is a senior consultant physician and gastroenterologist, and former Director-General of Health Malaysia, a role he held until retiring from public service in May 2025. He began his medical career in 1991 after earning the Licentiate of the Royal College of Physicians (Dublin), later obtaining his MRCP (UK) 1997 and Master of Medicine from Universiti Sains Malaysia (USM) in 1998.

He completed subspecialty training in gastroenterology and hepatology through the Ministry of Health, USM, and the Royal Melbourne Hospital, Australia. He served in major hospitals including Hospital Kuala Lumpur, Hospital Kota Bharu, and Hospital Kuala Terengganu, before being posted to Hospital Sultanah Bahiyah in 2001. There, he led the Medical Department (2005-2017) and headed the Clinical Research Centre Kedah.

Nationally, Dr Radzi was Head of Service for Gastroenterology and Hepatology (2013-2020), Internal Medicine (2021-2022), and later served as Deputy Director-General of Health (Research and Technical Support) before becoming Director-General of Health.

He played a key role in developing national clinical guidelines, particularly for hepatitis C and colorectal cancer screening. He has authored over 100 scientific publications, mainly in viral hepatitis, metabolic syndromes, and colorectal cancer. He is also dedicated to advancing the green and planetary health agenda in Ministry of Health. His outstanding leadership in advancing green accreditation for healthcare facilities earned him the Sustainability Leadership Award at the 2025 Green Healthcare Facilities Conference.
Directorships in public companies and listed issuers (if any)
Nil
Family relationship with any director and/or major shareholder of the listed issuer
Nil
Any conflict of interests that he/she has with the listed issuer
Nil
Details of any interest in the securities of the listed issuer or its subsidiaries
Nil




Announcement Info

Company Name NOVA WELLNESS GROUP BERHAD
Stock Name NOVA
Date Announced 26 Aug 2025
Category Change in Boardroom
Reference Number C03-18062025-00008